ストックスクリーナーアプリを入手
76.85
0.50%
-0.39
アフターアワーズ：
76.85
Ptc Therapeutics Inc (PTCT) 最新ニュース
PTC Therapeutics (NASDAQ:PTCT) EVP Sells $49,742.16 in Stock - MarketBeat
Neil Gregory Almstead Sells 1,026 Shares of PTC Therapeutics (NASDAQ:PTCT) Stock - MarketBeat
Insider Selling: PTC Therapeutics (NASDAQ:PTCT) Insider Sells 1,352 Shares of Stock - MarketBeat
Insider Selling: PTC Therapeutics (NASDAQ:PTCT) Insider Sells 1,279 Shares of Stock - MarketBeat
Insider Selling: PTC Therapeutics (NASDAQ:PTCT) CFO Sells 2,139 Shares of Stock - MarketBeat
PTC Therapeutics (NASDAQ:PTCT) Insider Eric Pauwels Sells 1,789 Shares - MarketBeat
PTC Therapeutics (NASDAQ:PTCT) CEO Matthew Klein Sells 5,149 Shares - MarketBeat
Insider Selling: PTC Therapeutics (NASDAQ:PTCT) VP Sells 4,879 Shares of Stock - MarketBeat
Published on: 2026-01-09 07:20:07 - moha.gov.vn
Is PTC Therapeutics Inc. stock a safe haven assetEarnings Risk Report & Growth Focused Stock Pick Reports - ulpravda.ru
PTC Therapeutics Executives Engage in Stock Transactions - TradingView — Track All Markets
PTC Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - PR Newswire
Is PTC Therapeutics Inc. stock a defensive play in 20252025 Price Targets & Smart Investment Allocation Tips - ulpravda.ru
What dividend safety score for PTC Therapeutics Inc. stockQuarterly Market Summary & High Yield Stock Recommendations - ulpravda.ru
PTC Therapeutics Inc (NASDAQ:PTCT) Nasdaq Composite Genetic Precision - Kalkine Media
PTC THERAPEUTICS, INC. (PTCT) - MSN
PTC Therapeutics (NASDAQ:PTCT) VP Sells $171,196.30 in Stock - MarketBeat
PTC Therapeutics (NASDAQ:PTCT) Director Emma Reeve Sells 734 Shares - MarketBeat
Glenn Md Phd Steele Jr Sells 12,000 Shares of PTC Therapeutics (NASDAQ:PTCT) Stock - MarketBeat
PTC Therapeutics Inc (PTCT) - MSN
PTC Therapeutics, Inc. (PTCT) Stock Analysis: Navigating the Biotech Frontier with a 6.64% Potential Upside - DirectorsTalk Interviews
Is PTC Therapeutics Inc. stock supported by innovation pipeline2026 world cup usa national team round of 16 star players high defensive line odds analysis expert opinion - ulpravda.ru
PTC Therapeutics (NASDAQ:PTCT) Upgraded to Buy at Wall Street Zen - MarketBeat
Matthew Klein Sells 8,089 Shares of PTC Therapeutics (NASDAQ:PTCT) Stock - MarketBeat
PTC Therapeutics CEO Sells Shares to Cover Tax Obligations - TradingView — Track All Markets
Behavioral Patterns of PTCT and Institutional Flows - Stock Traders Daily
What's Going On With Royalty Pharma Stock Wednesday? - Benzinga
Duchenne Muscular Dystrophy (DMD) Therapeutics Market to Reach - openPR.com
Royalty Pharma Acquires Remaining Evrysdi Royalties From PTC Therapeutics - Nasdaq
Royalty Pharma Acquires Final Portion of Evrysdi Royalty from PTC Therapeutics for $240 Million - Quiver Quantitative
PTC Therapeutics Fully Monetizes Evrysdi Royalty Interest - TipRanks
PTC Therapeutics Signs Royalty Purchase Agreement Amendment With Royalty Pharma - TradingView — Track All Markets
PTC Therapeutics fully monetizes Evrysdi royalty interest - MSN
PTC Therapeutics Swings to a Profit on $211 Million in Revenue — Is This Why a Major Fund Just Invested $32 Million? - AOL.com
Pacer Advisors Inc. Has $30.93 Million Stock Position in PTC Therapeutics, Inc. $PTCT - MarketBeat
Weekly Buzz: FDA OKs Roche's Lunsumio VELO; It's No For Tolbrutinib; BioMarin, SNY Open Wallets - RTTNews
PTC Therapeutics Earnings Notes - Trefis
PTC Therapeutics (NASDAQ:PTCT) Insider Eric Pauwels Sells 20,508 Shares of Stock - MarketBeat
PTC Therapeutics Executive Eric Pauwels Sells Over 20,000 Shares - TradingView — Track All Markets
Director Reeve Emma exercised 733 shares at a strike of $46.54 and sold $57,628 worth of shares (733 units at $78.62) (SEC Form 4) - Quantisnow
PTC Therapeutics Announces Approval of Sephience™ (sepiapterin) for the Treatment of Children and Adults Living with Phenylketonuria (PKU) in Japan - Sahm
Japan Sephience Approval Could Be A Game Changer For PTC Therapeutics’ (PTCT) Rare-Disease Strategy - Yahoo Finance
PTC Therapeutics (PTCT): Valuation Check After First Japan Approval Completes Global Sephience Launch - Yahoo Finance
(PTCT) Volatility Zones as Tactical Triggers - news.stocktradersdaily.com
PTC Therapeutics Announces Approval of Sephience™ (sepiapterin) - GuruFocus
PTC Therapeutics' Phenylketonuria Treatment Approved in Japan - marketscreener.com
PTC Therapeutics receives Japan approval for PKU treatment Sephience By Investing.com - Investing.com Nigeria
Voya Investment Management LLC Has $17.48 Million Position in PTC Therapeutics, Inc. $PTCT - MarketBeat
PTCT Gains Japanese Approval for Phenylketonuria Treatment - GuruFocus
PTC Therapeutics receives Japan approval for PKU treatment Sephience - Investing.com
PTC Therapeutics, Inc. $PTCT Shares Sold by Assenagon Asset Management S.A. - MarketBeat
PTC Therapeutics Announces Approval of Sephience™ (sepiapterin) for the Treatment of Children and Adults Living with Phenylketonuria (PKU) in Japan – Company Announcement - Financial Times
PTC Therapeutics Shares Drop After FDA Rejects Vatiquinone Application - MSN
Assessing PTC Therapeutics (PTCT) Valuation After Health Canada’s Sephience Approval Expands PKU Market Potential - Sahm
EPS Watch: Why millennials buy PTC Therapeutics Inc. (BH3) stock2025 Winners & Losers & Short-Term Swing Trade Alerts - ulpravda.ru
PTC Therapeutics (PTCT) Gets a Buy from Wells Fargo - The Globe and Mail
Will PTC Therapeutics Inc. stock attract more institutional investors2025 Trading Volume Trends & Accurate Buy Signal Notifications - Улправда
Insider Sell Alert: Eric Pauwels Sells 43,492 Shares of PTC Ther - GuruFocus
Eric Pauwels Sells 3,202 Shares of PTC Therapeutics (NASDAQ:PTCT) Stock - MarketBeat
PTC Therapeutics Executive Eric Pauwels Sells Over $3 Million in Company Stock - TradingView — Track All Markets
Officer Pauwels Files To Sell 20,508 Of PTC Therapeutics Inc [PTCT] - TradingView — Track All Markets
Is PTC Therapeutics Inc. (BH3) stock undervalued by metricsQuarterly Portfolio Report & Free Reliable Trade Execution Plans - Улправда
Why PTC Therapeutics Inc. stock remains resilient2025 Price Momentum & Daily Volume Surge Trade Alerts - DonanımHaber
Aug Catalysts: Is PTC Therapeutics Inc. (BH3) stock undervalued by metrics2025 Investor Takeaways & Real-Time Volume Spike Alerts - ulpravda.ru
0.80%
4.56%
大文字化:
|
ボリューム (24 時間):